InsiderClue
Insiders · Profile

Cittadine Andrew

Chief Operating Officer at Monopar Therapeutics. Filing since 14 Nov 2022. CIK 0001863624

Company
Date
Role
Action
Shares
Amount
Of holding
MNPR Monopar Therapeutics
20 Jun 2024
Chief Operating Officer
Bought
20,508
$15.25K
12.4%
MNPR Monopar Therapeutics
18 Jun 2024
Chief Operating Officer
Bought
12,000
$10.32K
7.8%
MNPR Monopar Therapeutics
17 Jun 2024
Chief Operating Officer
Bought
12,000
$10.80K
8.5%
MNPR Monopar Therapeutics
14 Jun 2024
Chief Operating Officer
Bought
12,000
$11.18K
9.3%
MNPR Monopar Therapeutics
13 Jun 2024
Chief Operating Officer
Bought
12,000
$10.92K
10.2%
MNPR Monopar Therapeutics
4 Jun 2024
Chief Operating Officer
Bought
12,000
$9.36K
11.4%
MNPR Monopar Therapeutics
3 Jun 2024
Chief Operating Officer
Bought
12,000
$9.12K
12.8%
MNPR Monopar Therapeutics
31 May 2024
Chief Operating Officer
Bought
12,000
$7.73K
14.7%
MNPR Monopar Therapeutics
30 May 2024
Chief Operating Officer
Bought
12,000
$7.68K
17.2%
MNPR Monopar Therapeutics
29 May 2024
Chief Operating Officer
Bought
12,000
$7.64K
20.8%
MNPR Monopar Therapeutics
15 Nov 2022
Chief Operating Officer
Bought
10,000
$31.50K
70.2%
MNPR Monopar Therapeutics
14 Nov 2022
Chief Operating Officer
Bought
6,053
$18.16K
74.0%
12 decisions on file.